Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical applications of genome editing in HIV

7 Apr 2016

Abstract excerpt

HIV/AIDS has long been at the forefront of the development of gene- and cell-based therapies. Although conventional gene therapy approaches typically involve the addition of anti-HIV genes to cells using semirandomly integrating viral vectors, newer genome editing technologies based on engineered nucleases are now allowing more precise genetic manipulations. The possible outcomes of genome editing include gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to HIV Research and Treatment
Share to Mosquito-borne diseases and control

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27053530
DOI: 10.1182/blood-2016-01-678144

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical applications of genome editing in HIVPMID 27053530Read ↗

Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly.Semantic proximity Read ↗

The therapeutic landscape of HIV-1 via genome editingSemantic proximity Read ↗

Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5.Semantic proximity Read ↗

Genome-editing Technologies for Gene and Cell TherapySemantic proximity Read ↗

Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV‐1 InfectionSemantic proximity Read ↗

Newer Gene Editing Technologies toward HIV Gene TherapySemantic proximity Read ↗

Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infectionSemantic proximity Read ↗

Genome editing-based HIV therapiesSemantic proximity Read ↗

A CRISPR-Cas9 Genome Engineering Platform in Primary CD4+ T Cells for the Interrogation of HIV Host FactorsSemantic proximity Read ↗

Efficient modification of <i>CCR5</i> in primary human hematopoietic cells using a megaTAL nuclease and AAV donor templateSemantic proximity Read ↗

Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivoSemantic proximity Read ↗

The clinical potential of gene editing as a tool to engineer cell‐based therapeuticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.